ACADL and alcoholic liver diseases: We summarize the expression of these DEGs involved in the above two KEGG pathways (fatty acid degradation, and alcoholic liver disease) in Figure 4C. Our findings (Figure 4D) indicate that the PS group elevated (p < 0.05) the expression of acyl-CoA dehydrogenase very long chain (ACADVL), carnitine palmitoyl transferase (CPT) 1A, and malonyl-CoA decarboxylase (MLYCD), and reduced (p < 0.05) the expression level of cytochrome P450 2U1 (CYP2U1) and aldehyde dehydrogenase 1B1 (ALDH1B1) in the liver.